retatrutide drug Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation RETATRUTIDE (RETA) – Research Peptide

I am happy with the product as I am seeing positive results

Below is a comprehensive timeline based on published data from the STEP trials for semaglutide, the SURMOUNT trials for tirzepatide, and thousands of documented patient experiences

Headaches may recur briefly after dose increases but typically resolve with continued use and supportive measures like adequate hydration

For patients using GLP-1 medications or considering future therapies like retatrutide, the goal should be fat loss with lean-mass protection

But without a targeted fitness and nutrition plan, its easy to: Lose muscle along with fat Feel tired, dizzy, or weak from nutrient gaps Regain weight when the medication stops or the dose changes We help you build strength, maintain muscle, and create eating habits that will keep you feeling and looking your best for life